PU.1 and a TTTAAA element in the myeloid Defensin-1 promoter create an operational TATA box that can impose cell specificity onto TFIID function

Journal of Immunology

Volumn 176, Issue 11, 2006, Pages 6906-6917

  Yaneva, Mariana ^a   Kippenberger, Serena ^a   Wang, Nan ^a   Su, Qin ^a   McGarvey, Margaret ^a   Nazarian, Arpi ^a   Lacomis, Lynne ^a   Erdjument Bromage, Hediye ^a   Tempst, Paul ^a,b  

^a Weill Cornell Graduate School of Biomedical Sciences   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; DEFENSIN; DEFENSIN BINDING PROTEIN; ENZYME ACTIVATOR; GA BINDING PROTEIN ALPHA; GA BINDING PROTEIN BETA; PROTEIN KINASE INHIBITOR; TRANSCRIPTION FACTOR IID; TRANSCRIPTION FACTOR PU 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL SPECIFICITY; CELL STRAIN HL 60; EVOLUTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKEMIA; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TATA BOX; TRANSCRIPTION INITIATION SITE;

EID: 33646939862     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.11.6906     Document Type: Article

References (61)

1. You, A. 2001. Differentiation, apoptosis, and function of human immature and mature myeloid cells: intracellular signaling mechanism. Int. J. Hematol. 73: 438-452.
2. Lehrer, R. I., and T. Ganz. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 4: 96-102.
3. Ganz, T. 2003. Defensins: antimicrobial peptides of innate immunity. Nat. Rev. Immunol. 3: 710-720.
4. Lehrer, R. I., A. K. Lichtenstein, and T. Ganz. 1993. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu. Rev. Immunol. 11: 105-128.
5. Zhang, L., W. Yu, T. He, R. E. Caffrey, E. A. Dalmasso, S. Fu, T. Pham, J. Mei, J. Ho, W. Zhang, et al. 2002. Contribution of human α-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor. Science 298: 995-1000.
6. Wiedmann, L. M., G. E. Frances, R. F. Lamb, J. H. Burns, J. N. Winnie, E. D. McKenzie, and G. D. Birnie. 1989. Differentiation stage-specific expression of a gene during granulopoiesis. Leukemia 3: 227-234.
7. Mars, W. M., P. Van Tuinen, H. A. Drabkin, J. W. White, and G. F. Saunders. 1988. A myeloid-related sequence that localizes to human chromosome 8q21.1-22. Blood 71: 1713-1719.
8. Daher, K. A., R. I. Lehrer, T. Ganz, and M. Kronenberg. 1988. Isolation and characterization of human defensin cDNA clones. Proc. Natl. Acad. Sci. USA 85: 7327-7331.
9. Hirata, R. K., S. T. Chen, and S. C. Weil. 1993. Expression of granule protein mRNAs in acute promyelocytic leukemia. Hematol. Pathol. 7: 225-238.
10. Bateman, A., A. Singh, C. Shustik, W. M. Mars, and S. Solomon. 1991. The isolation and identification of multiple forms of the neutrophil granule peptides from human leukemic cells. J. Biol. Chem. 266: 7524-7530.
11. Valore, E. V., and T. Ganz. 1992. Posttranslational processing of defensins in immature human myeloid cells. Blood 79: 1538-1544.
12. Herwig, S., Q. Su, W. Zhang, Y. Ma, and P. Tempst. 1996. Distinct temporal patterns of defensin mRNA regulation during drug-induced differentiation of human myeloid leukemia cells. Blood 87: 350-364.
13. Koeffler, H. P. 1983. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood 62: 709-721.
14. Collins, S. J. 1987. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood 70: 1233-1244.
15. Lubbert, M., F. Herrmann, and P. H. Koeffler. 1991. Expression and regulation of myeloid-specific genes in normal and leukemic myeloid cells. Blood 77: 909-924.
16. Zhang, D. E., S. Hohaus, M. T. Voso, H. M. Chen, L. T. Smith, C. J. Hetherington, and D. G. Tenen. 1996. Function of PU.1 (Spi-1), C/EBP, and AML1 in early myelopoiesis: regulation of multiple myeloid CSF receptor promoters. Curr. Top. Microbiol. Immunol. 211: 137-147.
17. Friedman, A. D. 2002. Transcriptional regulation of granulocyte and monocyte development. Oncogene 21: 3377-3390.
18. Rosmarin, A. G., K. K. Resendes, Z. Yang, J. N. McMillan, and S. L. Fleming. 2004. GA-binding protein transcription factor: a review of GABP as an integrator of intracellular signaling and protein-protein interactions. Blood Cells Mol. Dis. 32: 143-154.
19. Tenen, D. G., R. Hromas, J. D. Licht, and D. E. Zhang. 1997. Transcription factors, normal myeloid development, and leukemia. Blood 90: 489-519.
20. Sementchenko, V. I., and D. K. Watson. 2000. Ets target genes: past, present and future. Oncogene 19: 6533-6548.
21. Skalnik, D. G. 2002. Transcriptional mechanisms regulating myeloid-specific genes. Gene 284: 1-21.
22. Holmberg, C. I., S. E. Tran, J. E. Eriksson, and L. Sistonen. 2002. Multisite phosphorylation provides sophisticated regulation of transcription factors. Trends Biochem. Sci. 27: 619-627.
23. Herwig, S., Q. Su, and P. Tempst. 1998. Drug-activated multiple pathways of defensin mRNA regulation in HL-60 cells are defined by reversed roles of participating protein kinases. Leukemia Res. 22: 913-925.
24. Wang, N., S. Boeckh-Herwig, M. Yaneva, and P. Tempst. 2004. Delayed late activation of a myeloid defensin minimal promoter by retinoids and inflammatory mediators. Leukemia Res. 28: 879-889.
25. Ma, Y., Q. Su, and P. Tempst. 1998. Differentiation-stimulated activity binds an ETS-like, essential regulatory element in the human promyelocytic defensin-1 promoter. J. Biol. Chem. 273: 8727-8740.
26. Tsutsumi-Ishii, Y., T. Hasebe, and I. Nagaoka. 2000. Role of CCAAT/Enhancer-binding protein site in transcription of human neutrophil peptide-1 and -3 defensin genes. J. Immunol. 164: 3264-3273.
27. Tsutsumi-Ishii, Y., and I. Nagaoka. 2002. NK-κB-mediated transcriptional regulation of human β-defensin-2 gene following lipopolysaccharide stimulation. J. Leukocyte Biol. 71: 154-162.
28. Lanotte, M., V. Martin-Thouvenin, S. Najman, P. Balerini, F. Valensi, and R. Berger. 1991. NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77: 1080-1086.
29. Hemat, F., and K. McEntee. 1994. A rapid and efficient PCR-based method for synthesizing high-molecular-weight multimers of oligonucleotides. Biochem. Biophys. Res. Commun. 205: 475-481.
30. Yaneva, M., and P. Tempst. 2003. Affinity capture of specific DNA-binding proteins for mass spectrometric identification. Anal. Chem. 75: 6437-6448.
31. Dignam, J. D., P. L. Martin, B. S. Shastry, and R. G. Roeder. 1983. Eukaryotic gene transcription with purified components. Methods Enzymol. 101: 582-598.
32. Erdjument-Bromage, H., M. Lui, L. Lacomis, A. Grewal, R. S. Annan, D. McNulty, S. A. Carr, and P. Tempst. 1998. Examination of micro-tip reversed-phase liquid chromatographic extraction of peptide pools for mass spectrometric analysis. J. Chromatogr. 826: 167-181.
33. Winkler, G. S., L. Lacomis, J. Philip, H. Erdjument-Bromage, J. Q. Svejstrup, and P. Tempst. 2002. Isolation and mass spectrometry of transcription factor complexes. Methods 26: 260-269.
34. Klemsz, M. J., S. R. McKercher, A. Celada, C. Van Beveren, and R. A. Maki. 1990. The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene. Cell 61: 113-124.
35. LaMarco, K., C. C. Thompson, B. P. Byers, E. M. Walton, and S. L. McKnight. 1991. Identification of Ets- and Notch-related subunits in GA binding protein. Science 253: 789-792.
36. Castanon, I., S. Von Stetina, J. Kass, and M. K. Baylies. 2001. Dimerization partners determine the activity of the twist bHLH protein during Drosophila mesoderm development. Development 128: 3145-3159.
37. Thompson, C. C., T. A. Brown, and S. L. McKnight. 1991. Convergence of Ets- and notch-related structural motifs in a heteromeric DNA binding complex. Science 253: 762-768.
38. 2 leukocyte imegrin) transcription. J. Biol. Chem. 270: 23627-23633.
39. Schweppe, R. E., A. A. Melton, K. S. Brodsky, L. D. Aveline, K. A. Resing, N. G. Ahn, and A. Gutierrez-Hartman. 2003. Purification and mass spectrometric identification of GA-binding protein (GABP) as the functional pituitary Ets factor binding to the basal transcription element of the prolactin promoter. J. Biol. Chem. 278: 16863-16872 .
40. Kamura, T., H. Handa, N. Hamasaki, and S. Kitajima. 1997. Characterization of the human thrombopoietin gene promoter: a possible role of an Ets transcription factor, E4TF1/GABP. J. Biol. Chem. 272: 11361-11368.
41. phox transcription during granulocytic differentiation of myeloid cells. Blood 99: 4578-4587.
42. Shimokawa, T., and C. Ra. 2005. C/EBPα functionally and physically interact with GABP to activate the human myeloid IgA Fc receptor (FcαR, CD89) gene promoter. Blood 106: 2534-2542.
43. Smale, S. T., and J. Kadonaga. 2003. The RNA polymerase II core promoter. Annu. Rev. Biochem. 72: 449-479.
44. Bucher, P. 1990. Weight matrix descriptions of four eukaryotic RNA polymerase II promoter elements derived from 502 unrelated promoter sequences. J. Mol. Biol. 212: 563-578.
45. Ray-Gallet, D., C. Mao, A Tavitian, and F. Moreau-Gachelin. 1995. DNA binding specificities of Spi-1/PU.1 and Spi-B transcription factors and identification of a Spi-1/Spi-B binding site in the c-fes/c-fps promoter. Oncogene 11: 303-313.
46. Scott, E. W., M. C. Simon, J. Anastasi, and H. Singh. 1994. Requirement of transcription factor PU.1 in the development of multiple hematopoietic lineages. Science 26: 1573-1577.
47. Scott, E. W., R. C. Fisher, M. C. Olson, E. W. Kehrli, M. C. Simon, and H. Singh. 1997. PU.1 functions in a cell-autonomous manner to control the differentiation of multipotential lymphoid-myeloid progenitors. Immunity 6: 437-447.
48. Chen, H. M., P. Zhang, M. T. Voso, S. Hohaus, D. A. Gonzales, C. K. Glass, D. E. Zhang, and D. G. Tenen. 1995. Neutrophils and monocytes express high levels of PU.1 (Spi-1) but not Spi-B. Blood 85: 2918-2928.
49. Lloberas, J., C. Soler, and A. Celada. 1999. The key role of PU.1/SPI-1 in B cells, myeloid cells and macrophages. Immunol. Today 20: 184-189.
50. 4 integrin gene promoter. J. Biol. Chem. 269: 15652-15660.
51. Nuchprayoon, I., C. P. Simkevich, M. L. Luo, A. D. Friedman, and A. G. Rosmarin. 1997. GABP cooperates with c-Myb and C/EBP to activate the neutrophil elastase promoter. Blood 89: 4546-4554.
52. 2 leukocyte integrin) promoter. J. Biol. Chem. 273: 13097-13103.
53. Hagemeier, C., A. J. Bannister, A. Cook, and T. Kouzarides. 1993. The activation domain of transcription factor PU.1 in vitro binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90: 1580-1599.
54. Eichbaum, Q. G., R. Iyer, D. P. Raveh, C. Mathieu, and R. A. Ezekowitz. 1994. Restriction of interferon y responsiveness and basal expression of the myeloid human FcyR1b gene is mediated by a functional PU.1 site and transcription initiator consensus. J. Exp. Med. 179: 1985-1996.
55. Lodie, T. A., R. Savedra, D. T. Golenbock, C. P. Van Beveren, R. A. Maki, and M. J. Fenton. 1997. Stimulation of macrophages by lipopolysaccharide alters the phosphorylation state, conformation, and function of PU.1 via activation of casein kinase II. J. Immunol. 158: 1848-1856.
56. Kim, Y. M., H. S. Kang, S. G. Paik, K. H. Pyun, K. L. Anderson, B. E. Torbett, and I. Choi. 1999. Roles of IFN consensus sequence binding protein and PU.1 in regulating IL-18 gene expression. J. Immunol. 163: 2000-2007.
57. Shackelford, R., D. O. Adams, and S. P. Johnson. 1995. IFN-γ and lipopolysaccharide induce DNA binding of transcription factor PU.1 in murine tissue macrophages. J. Immunol. 154: 1374-1382.
58. phox gene transcription is associated with changes in PU.1 phosphorylation and increased binding affinity. Biochem. Biophys. Res. Commun. 305: 193-202.
59. Avots, A., E. Hoffmeyer, A. Flory, U. R. Cimanis, E. Rapp, and E. Serfling. 1997. GABP factors bind to a distal interleukin 2 (IL-2) enhancer and contribute to c-Raf-mediated increase in IL-2 induction. Mol. Cell. Biol. 17: 4381-4389.
60. Hoffmeyer, E., A. Avots, A. Flory, C. K. Weber, E. Serfling, and U. R. Rapp. 1998. The GABP-responsive element of the interleukin-2 enhancer is regulated by JNK/SAPK-activating pathways in T lymphocytes. J. Biol. Chem. 273: 10112-10119.
61. 2 leukocyte integrin): a novel mechanism of transcriptional regulation in myeloid cells. Blood 101: 311-317. Vol. 176, No. 11